A prospective cohort of transgender and nonbinary adolescents starting gender‑affirming care shows measurable changes in depression, anxiety, and self‑harm reports in the first year after initiation. The study tracks initiation of puberty blockers and gender‑affirming hormones and uses validated scales (PHQ‑9, GAD‑7) to quantify short‑term mental‑health trajectories.
— Short‑term, clinic‑based evidence on mental‑health effects after starting gender‑affirming interventions matters for clinicians, parents, and lawmakers debating access and timing of care for minors.
2022.05.04
100% relevant
Prospective observational cohort at an urban multidisciplinary gender clinic (Aug 2017–Jun 2018) measuring PHQ‑9 and GAD‑7 changes and linking them to receipt of puberty blockers (PBs) or gender‑affirming hormones (GAHs).
← Back to All Ideas